Stay updated with breaking news from Everylife Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
People treated with gene therapy cannot receive a second dose for fear of a dangerous immune response. Researchers hope to find a way around this. People treated with gene therapy cannot receive a second dose for fear of a dangerous immune response. Researchers hope to find a way around this.
SAN DIEGO, Feb. 29, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. , a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates ,...
/PRNewswire/ -- On February 8, 2024, The Speak Foundation, a patient-led 501(c)(3) organization for Limb-Girdle Muscular Dystrophy (LGMD), convened a...
Patients will gather on Capitol Hill to talk to members of Congress and build community as part of Rare Disease Week.
Roth was previously VP of marketing and communication.